scholarly article | Q13442814 |
P50 | author | Toine Egberts | Q57121903 |
Mark de Groot | Q60611611 | ||
Eibert R. Heerdink | Q60717637 | ||
P2093 | author name string | E C G van Geffen | |
R van Hulten | |||
S W van der Wal | |||
P2860 | cites work | Postmarketing surveillance of enalapril. I: Results of prescription-event monitoring | Q28359865 |
Patient risk profiles and practice variation in nonadherence to antidepressants, antihypertensives and oral hypoglycemics. | Q33281702 | ||
Incidence and duration of side effects and those rated as bothersome with selective serotonin reuptake inhibitor treatment for depression: patient report versus physician estimate | Q33980401 | ||
The value of reporting therapeutic ineffectiveness as an adverse drug reaction | Q34005788 | ||
Determinants of signal selection in a spontaneous reporting system for adverse drug reactions | Q34459049 | ||
Patient adherence in the treatment of depression | Q34514178 | ||
Treatment non-adherence in affective disorders. | Q34592227 | ||
Adherence to maintenance-phase antidepressant medication as a function of patient beliefs about medication | Q34629048 | ||
Improving adherence to antidepressants: a systematic review of interventions | Q35631511 | ||
Patient reporting of suspected adverse drug reactions: a review of published literature and international experience. | Q36024366 | ||
Attitudinal survey of voluntary reporting of adverse drug reactions | Q36053857 | ||
The role of the primary care physician in patients' adherence to antidepressant therapy. | Q40570973 | ||
Can adverse drug reactions be detected earlier? A comparison of reports by patients and professionals. | Q41966060 | ||
Spontaneous lapses in dosing during chronic treatment with selective serotonin reuptake inhibitors | Q43814364 | ||
Discontinuing or switching selective serotonin-reuptake inhibitors | Q43936402 | ||
Physician alerts to increase antidepressant adherence: fax or fiction? | Q50114973 | ||
High Medication Discontinuation Rates in Psychiatry | Q58809502 | ||
Compliance with antidepressants in a primary care setting, 1: Beyond lack of efficacy and adverse events | Q74617402 | ||
[Direct reporting of side effects by the patient: favourable experience in the first year] | Q81555529 | ||
P433 | issue | 12 | |
P304 | page(s) | 1193-1199 | |
P577 | publication date | 2007-09-15 | |
P1433 | published in | European Journal of Clinical Pharmacology | Q1376707 |
P1476 | title | Evaluation of patients' experiences with antidepressants reported by means of a medicine reporting system | |
P478 | volume | 63 |
Q34792882 | A Pill for the Ill? Patients' Reports of Their Experience of the Medical Encounter in the Treatment of Depression |
Q37588434 | Antidepressants in primary care: patients' experiences, perceptions, self-efficacy beliefs, and nonadherence |
Q36015119 | Consumer Narratives in ADR Reporting: An Important Aspect of Public Health? Experiences from Reports to a Swedish Consumer Organization |
Q81407191 | Current awareness: pharmacoepidemiology and drug safety |
Q43443984 | Economic factors in of patients' nonadherence to antidepressant treatment |
Q34519989 | Experiences from consumer reports on psychiatric adverse drug reactions with antidepressant medication: a qualitative study of reports to a consumer association |
Q35097961 | Implementing guidelines for depression on antidepressant prescribing in general practice: a quasi-experimental evaluation |
Q38240932 | Issues in online patient self-reporting of health status. |
Q26752684 | Patient Participation and the Use of Ehealth Tools for Pharmacoviligance |
Q28645804 | Pharmacovigilance from social media: mining adverse drug reaction mentions using sequence labeling with word embedding cluster features |
Q39214070 | Primary-care patients' trade-off preferences with regard to antidepressants. |
Q26796436 | Profile of vortioxetine in the treatment of major depressive disorder: an overview of the primary and secondary literature |
Q50739616 | Reasons for and time to discontinuation of rimonabant therapy: a modified prescription-event monitoring study. |
Q34677835 | Serotonin and Antidepressant SSRIs Inhibit Rat Neuroendocrine Dopamine Neurons: Parallel Actions in the Lactotrophic Axis. |
Q38190342 | TIDAL WAVES: Network mechanisms in the neuroendocrine control of prolactin release |
Q38648733 | The Role of Curcumin Administration in Patients with Major Depressive Disorder: Mini Meta-Analysis of Clinical Trials |
Q34057639 | What can we learn from consumer reports on psychiatric adverse drug reactions with antidepressant medication? Experiences from reports to a consumer association |